摘要
瞄准:为了学习,增生的胃的息肉上的药物疗法的效果与 Helicobacter 感染了 pylori (H pylori ) 。方法:有感染 H pylori 的增生的胃的息肉(在直径的 3-10 公里)的 48 个病人随机被分到一个治疗组( n = 24 )它收到了质子泵禁止者( omeprazole 或 lansoprazole ), clarithromycin ,枸橼酸铋和 tinidazole ,并且控制组织( n = 24 )它收到了胃粘膜( tepretone )的保护的代理人。病人们在注册和 1-12 瞬间术后疗法前定期经历了内视镜检查法和 H pylori 检查。结果:在治疗的 22 个病人组织, 21 在控制组织完成了全部测试协议。在治疗组,息肉消失了 1-12 瞬间(平均, 6.5+/-1.1 瞬间) 在在 22 中的 15 个的治疗以后,病人(68.2%) 和 H pylori 感染在 22 个病人(86.4%) 中的 19 个被根除。然而,在学习,在息肉的没有变化或 H pylori 地位以后的 12 个月在任何控制((b) P【0.01 ) 被看见。结论:最增生的胃的息肉消失在 H pylori 的根除以后。
AIM: To study the effects of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori (H pylori. METHODS: Forty-eight patients with hyperplasticgastric polyps (3-10 mm in diameter) infected with Hpylori were randomly assigned to a treatment group (n = 24) which received proton-pump inhibitor (omeprazole or lansoprazole), clarithromycin, bismuth citrate and tinidazole, and a control group (n = 24) which received protective agent of gastric mucosa (tepretone) . Patients underwent endoscopy and H pylori examination regularly before enrollmentand 1-12 mo after treatment. RESULTS: Twenty-two patients in the treatment group and 21 in the control group completed the entire test protocol. In the treatment group, polyps disappeared 1-12 mo (average, 6.5 ± 1.1 too) after the treatment in 15 of 22 patients (68.2%) and H pylori infection was eradicated in 19 of the 22 patients (86.4%). However, 12 months after the study, no change in polyps or H pylori status was seen in any controls (^bp 〈 0.01). CONCLUSION: Most hyperplastic gastric polyps disappear after eradication of H pylori.